targeted alpha therapy

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Persimmon plc targets around 12,500 home completions in 2026 after stronger first-half volumes, even as rising construction, energy and materials costs threaten margins across the United Kingdom housebuilding sector. Representative image.

Persimmon plc raises 2026 home completion target as £50m inflation hit threatens margin recovery

Volodymyr Zelenskyy’s first official visit to Serbia is deepening Kyiv-Belgrade trade and political ties even as Serbia maintains energy links with Russia. Representative image.

Zelenskyy visits Russia-friendly Serbia as Kyiv strikes deepen Moscow’s oil infrastructure crisis

Representative image: An Arko Corp convenience store fuel pump and forecourt in the United States, reflecting the Q2 2026 revenue beat, the 5.7% drop in retail same-store fuel gallons and the ARKO Petroleum Corp agreement to acquire U.S. Petroleum Partners for $205 million.

Arko Corp Q2 revenue tops $2.35bn as APC agrees to $205m USPP acquisition

Lexeo’s second cardiac gene therapy gains FDA support ahead of year-end update

AdvanCell strengthens cancer drug pipeline with $112m Series C funding

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapy, has successfully completed an oversubscribed $112 million Series…

byPallavi Madhiraju

February 4, 2025

Telix Pharmaceuticals advances prostate cancer treatment with successful TLX592 study

Telix Pharmaceuticals Limited (ASX: TLX) has announced the successful completion of the CUPID Phase I dose escalation study…

byPallavi Madhiraju

May 21, 2024

The Latest

Persimmon plc raises 2026 home completion target as £50m inflation hit threatens margin recovery

Zelenskyy visits Russia-friendly Serbia as Kyiv strikes deepen Moscow’s oil infrastructure crisis

Arko Corp Q2 revenue tops $2.35bn as APC agrees to $205m USPP acquisition

Lexeo’s second cardiac gene therapy gains FDA support ahead of year-end update

AdvanCell strengthens cancer drug pipeline with $112m Series C funding

Telix Pharmaceuticals advances prostate cancer treatment with successful TLX592 study

Persimmon plc raises 2026 home completion target as £50m inflation hit threatens margin recovery

Zelenskyy visits Russia-friendly Serbia as Kyiv strikes deepen Moscow’s oil infrastructure crisis

Arko Corp Q2 revenue tops $2.35bn as APC agrees to $205m USPP acquisition

Lexeo’s second cardiac gene therapy gains FDA support ahead of year-end update

Early lung cancer responses push ACR-2316 into a broader randomized trial

Willow Project: ConocoPhillips’ Alaska oil development advances toward early-2029 first production

UAE says Iranian missile hit ADNOC-linked vessel as Strait of Hormuz deal hangs in balance

Robinhood Markets company profile: How free trading became a crypto, banking and prediction-markets platform